AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Established / Legacy Medicines by Year
Other Established / Legacy Medicines — Europe product sales ($M) ($M)
AstraZeneca Other Established / Legacy Medicines: $34M in FY2025, down 20.9% from a year earlier.
Where the FY2025 figure comes from
“|| Other | 156 | (24) | (24) | (4) | n/m | 121 | (16) | (15) | 34 | (21) | (21) | 5 | 18 | 17”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Established / Legacy Medicines — Europe product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34 | -20.9% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 43 | -17.3% | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2023 | Dec 31, 2023 | 52 | -32.5% | Form 6-K FY2023Q4 Earnings Release ↗ |
| FY2022 | Dec 31, 2022 | 77 | +42.6% | Form 6-K FY2022Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | 54 | – | Form 6-K FY2021Q4 Earnings Release ↗ |
Breakdown
What makes up other Established / Legacy Medicines
Cite this data
StockData. (2026). AstraZeneca Other Established / Legacy Medicines ($M), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-legacy-eu
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.